Loading…

PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.11187-11189
Main Authors:	Zhang, Hanwen, Wang, Shuhua, Rupji, Manali, Wu, Chenxi, Chandrasekaran, Sanjay, Funk, Christopher R., King, Patrick J., Kollipara, Saketh, Rao, Ishani, Ayanru, Esohe, Duffy, Julia, Kaplow, Roberta, Abousaud, Aseala, Mehta, Aneesh, Roback, John D., Kalman, Daniel, Lyon, G. Marshall, Caridi-Scheible, Mark, Bisson, Gregory, Liu, Yuan, Coma, Silvia, Pachter, Jonathan A., Giver, Cynthia R., Waller, Edmund K.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!